3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
8
Fallopian Tube Neoplasms
5
Endometrial Neoplasms
5
Uterine Cervical Neoplasms
4
Melanoma
3
Carcinoma, Hepatocellular
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Wilms Tumor
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Interventions
Radiotherapy
4
Surveys and Questionnaires
3
Specimen Handling
2
Iohexol
2
Gemcitabine
2
spartalizumab
1
sodium thiosulfate
1
liposomal doxorubicin
1
X-Rays
1
Watchful Waiting
1
Vorinostat
1
Surgical Procedures, Operative
1
Sunitinib
1
Solutions
1
Saline Solution
1
Re-Irradiation
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Probiotics
1
Platinum
1
Particle Accelerators
1
Pafolacianine
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Lidocaine
1
Ketamine
1
Injections
1
Immunotherapy, Adoptive
1
Hyperthermic Intraperitoneal Chemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pelvic Neoplasms
×
X-Rays
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled